Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101260062B reveals a robust route for beta-aminopropenones, offering high yields and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN101314581B details a gold-catalyzed synthesis of N-sulfonyl ketimines offering mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN110776429A details a high-yield one-pot synthesis for Rasagiline intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Novel copper-catalyzed selenoamination route offers high purity naphthoquinone intermediates with simplified processing for pharmaceutical applications.
Patent CN1232519C details advanced Pd-catalyzed amination for high-purity benzofuran intermediates, offering significant supply chain and cost advantages.
Patent CN114805259A details a robust Ni@Al2O3 catalyst for furfurylamine production, offering superior stability and selectivity over conventional noble metal methods.
Patent CN1095830C details a novel amine exchange method for producing fungicide intermediates, offering improved safety and industrial scalability for agrochemical manufacturers.
Patent CN114957044B details a novel synthesis route preventing polycondensation. Offers high purity and scalable manufacturing for global polypeptide supply chains.
Patent CN102351710B details a safer, high-yield route to dicyclopropylmethylamine, eliminating sodium metal hazards for reliable pharmaceutical intermediate supply chains.
Novel cobalt-catalyzed reductive amination route for Vonoprazan fumarate. Ensures high yield, safety, and scalable supply chain reliability for global pharmaceutical partners.
Patent CN108658815A reveals a copper-catalyzed synthesis for amino-substituted conjugated enyne aldehydes, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104178533B details enzymatic synthesis of R-3-aminobutanol. Offers high purity, cost efficiency, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN113061094A details a cost-effective H-D exchange route for Ractopamine-D6. Achieve >98% purity and >96% isotopic abundance for LC-MS food safety testing.
Patent CN121342678A enables one-pot synthesis for high purity Safinamide Mesylate. Reduces waste and cost for reliable pharmaceutical intermediate supply chains.
Patent CN111072500B reveals a green 3-step synthesis for Ambroxol Hydrochloride. Discover cost reduction in API manufacturing and high-purity scalable routes.
Patent CN119350353A details safer synthesis of nalfurafine intermediate using formic acid reducing toxic waste and improving supply chain reliability for global buyers.
Novel synthesis avoids toxic amines. High purity hole transport materials. Cost-effective scale-up for display industry.
Patent CN113336665B reveals a metal-free route for arylamide synthesis using hypervalent iodine. This method offers mild conditions and high purity for pharmaceutical intermediates.
Novel reductive amination route for influenza inhibitor intermediates. High yield, safe scale-up, and cost-effective manufacturing solution for global pharma.
Patent CN112479968A reveals a room-temperature hydroamination route using KI/KHSO4, offering a cost-effective alternative to transition metals for pharmaceutical intermediates.